Wells Fargo & Company Spdr Ser Tr Spdr S&P Biotech E Transaction History

Wells Fargo & Company

$468 Billion
Q2 2025

A detailed history of Wells Fargo & Company transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Wells Fargo & Company holds 2,926,242 shares of XBI stock, worth $250 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,926,242

Previous 2,181,070 34.17%

Holding current value

$250 Million

Previous $177 Million 37.19%

% of portfolio

0.05%

Previous 0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$69.8 - $85.28 $52 Million - $63.5 Million	745,172 Added 34.17%	2,926,242 $243 Million
Q1 2025 May 13, 2025	SELL	$81.1 - $94.7 $1.23 Million - $1.44 Million	-15,191 Reduced 0.69%	2,181,070 $177 Million
Q4 2024 Feb 12, 2025	BUY	$89.81 - $104.0 $17 Million - $19.7 Million	189,004 Added 9.42%	2,196,261 $198 Million
Q3 2024 Nov 13, 2024	BUY	$90.87 - $102.43 $20.4 Million - $23 Million	224,565 Added 12.6%	2,007,257 $198 Million
Q2 2024 Aug 13, 2024	SELL	$82.22 - $94.12 $5.94 Million - $6.8 Million	-72,260 Reduced 3.9%	1,782,692 $165 Million
Q1 2024 May 10, 2024	BUY	$87.05 - $102.89 $120 Million - $142 Million	1,380,118 Added 290.65%	1,854,952 $176 Million
Q4 2023 Feb 09, 2024	SELL	$64.12 - $90.86 $4.07 Million - $5.77 Million	-63,534 Reduced 11.8%	474,834 $42.4 Million
Q3 2023 Nov 13, 2023	SELL	$71.88 - $85.76 $9.65 Million - $11.5 Million	-134,221 Reduced 19.96%	538,368 $39.3 Million
Q2 2023 Aug 15, 2023	SELL	$75.38 - $90.23 $4.52 Million - $5.41 Million	-59,903 Reduced 8.18%	672,589 $56 Million
Q1 2023 May 12, 2023	SELL	$73.13 - $91.97 $15 Million - $18.8 Million	-204,718 Reduced 21.84%	732,492 $55.8 Million
Q4 2022 Feb 13, 2023	SELL	$76.72 - $85.66 $2.75 Million - $3.06 Million	-35,780 Reduced 3.68%	937,210 $77.8 Million
Q3 2022 Nov 14, 2022	BUY	$75.06 - $94.9 $15.9 Million - $20.2 Million	212,475 Added 27.94%	972,990 $77.2 Million
Q2 2022 Aug 12, 2022	SELL	$62.81 - $96.09 $9.49 Million - $14.5 Million	-151,125 Reduced 16.58%	760,515 $56.5 Million
Q1 2022 May 16, 2022	BUY	$81.07 - $115.44 $7.85 Million - $11.2 Million	96,847 Added 11.89%	911,640 $81.9 Million
Q4 2021 Feb 14, 2022	SELL	$108.77 - $134.15 $14.4 Million - $17.8 Million	-132,615 Reduced 14.0%	814,793 $91.2 Million
Q3 2021 Nov 15, 2021	SELL	$118.69 - $138.49 $1.8 Million - $2.1 Million	-15,166 Reduced 1.58%	947,408 $119 Million
Q2 2021 Aug 16, 2021	SELL	$122.48 - $139.69 $4.4 Million - $5.02 Million	-35,961 Reduced 3.6%	962,574 $130 Million
Q1 2021 May 13, 2021	SELL	$129.36 - $173.99 $259 Million - $348 Million	-2,000,295 Reduced 66.7%	998,535 $135 Million
Q4 2020 Feb 09, 2021	BUY	$110.36 - $151.14 $203 Million - $278 Million	1,842,571 Added 159.36%	2,998,830 $422 Million
Q3 2020 Nov 05, 2020	SELL	$103.87 - $120.36 $11.9 Million - $13.8 Million	-114,322 Reduced 9.0%	1,156,259 $129 Million
Q2 2020 Aug 13, 2020	BUY	$73.26 - $114.17 $22.5 Million - $35 Million	306,890 Added 31.85%	1,270,581 $142 Million
Q1 2020 May 14, 2020	BUY	$65.95 - $98.35 $63.6 Million - $94.8 Million	963,691 New	963,691 $74.6 Million

Others Institutions Holding XBI

# of Institutions

801

Shares Held

111M

Call Options Held

22.4M

Put Options Held

28.8M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Spdr Ser Tr Spdr S&P Biotech E Transaction History